# Burning Point

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/burning-point

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Website: www.bpbiopharm.com
- Latest round: Series B (Jun 16, 2023)
- Investors on record: 4

## About

Established in 2019 and based in Nanjing, China, Burning Point operates as a new drugs developer that provides slow and controlled release formulations, complex injectables, and improved new drugs and innovative drugs. The company cooperates with China Pharmaceutical University, Nanjing University of Traditional Chinese Medicine and Nanjing University of Technology, etc. More than 50% employees of the core research team have PhD and master's degrees. And it has a 3000 square meter pharmacy research laboratory. In November 2022, the company awarded the title of high-tech enterprise. In April 2025, Burning Point raised CNY 50 million in series C funding from new investor Hunan Jiudian Pharmaceutical Co., Ltd.

The company provides pharmaceutical R&D services, including chemical API process, Chinese medicine and natural drug, and preparation process development, consistency evaluation, analysis and testing, clinical research, and registration filing. Its products include slow and controlled release formulations, complex injectables, and improved new drugs and innovative drugs. 

The company generates revenue by providing slow and controlled release formulations, complex injectables, and improved new drugs and innovative drugs.

The company will use the funds to build an industrial base for injections and conduct preclinical research on improved new drugs.

## Funding rounds

- Series B, Jun 16, 2023 — Sealand Innovation
- Angel, Jan 7, 2021 — Zijin Venture Capital, Yangtze River Capital, BGI Co-WIN Investment Management

## Investors

- Zijin Venture Capital (https://capitalatlas.ai/funds/zijin-venture-capital) — Angel
- Yangtze River Capital (https://capitalatlas.ai/funds/yangtze-river-capital) — Angel
- BGI Co-WIN Investment Management (https://capitalatlas.ai/funds/bgi-co-win-investment-management) — Angel
- Sealand Innovation (https://capitalatlas.ai/funds/sealand-innovation) — Series B